HIV-Positive kidneys for HIV-Positive patients: a lifesaving match?

NCT ID NCT05159466

Recruiting now Disease control Sponsor: Tulane University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether kidney transplants from HIV-positive donors are safe and effective for HIV-positive recipients. Researchers will follow 30 adults with HIV and end-stage kidney disease who receive a kidney from an HIV-positive donor. The goal is to learn more about patient survival and how well the transplanted kidney works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: kidney transplant
What this could lead to: If successful, this could expand the donor pool for HIV-positive patients needing kidney transplants, potentially reducing wait times and improving survival.
What could go wrong: This is an early observational study with only 30 participants, so results may not apply broadly. Risks include organ rejection, infection, and complications from surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS chronic kidney disease end stage renal failure HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

END-STAGE RENAL DISEASE HUMAN IMMUNODEFICIENCY VIRUS

Contacts and locations

Locations

East Jefferson General Hospital
RECRUITING

Metairie, Louisiana, 70006, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.